| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.28 | 6e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.35 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.05 |